Overview
Updated 14 Jul 2026
Erik Dubberke, MD, is Professor of Medicine at Washington University School of Medicine in St. Louis, Division of Infectious Diseases. The public record shows 373 publications with 18,789 citations (h-index 66), centered on Clostridium difficile and Clostridium perfringens research, Nosocomial Infections in ICU, Microscopic Colitis. It also documents an investigator role on 4 registered clinical trials, industry payments reported by 12 companies, 5 NIH-funded awards (2009–2026).
- Most recent indexed publication: 2026 · Open forum infectious diseases
- Top research focus: Clostridium difficile and Clostridium perfringens research
- 4 registered trials on ClinicalTrials.gov
- Open Payments reporting from 12 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 15 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 167.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 4 registered studies on ClinicalTrials.gov. The most recent:
- Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant
Sponsor: Washington University School of Medicine
InvestigatorPhase 1RecruitingNCT06523699 - TOX NEG Trial: Clostridium Difficile Diagnosis and Treatment
Sponsor: Washington University School of Medicine
InvestigatorPhase 4CompletedNCT03388268 - Fecal Microbiota Transplantation (FMT) for MDRO UTI
Sponsor: Washington University School of Medicine
InvestigatorPhase 1/PHASE2CompletedNCT03367910
Industry payments
Updated 14 Jul 2026
12 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca UK LimitedProgram year20252 payments
- PFIZER INC.Program year20253 payments
- IDORSIA PHARMACEUTICALS US INCProgram year20251 payment
NIH funding
Updated 14 Jul 2026
5 NIH research awards on record, funded 2009–2026 per NIH RePORTER. The latest:
- Phase 1b/2a Evaluation of the Safety and Tolerability of SYN-004 in Adult Allogeneic Hematopoietic Cell Transplantation (allo-HCT) Recipients
Washington University
FY2026$919,820U01AI195139 - High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection
Washington University
FY2026$767,314R01AI184858 - High-resolution genomic interrogation of pathogen-microbiome interactions in Clostridioides difficile infection
Washington University
FY2025$745,133R01AI184858
Congress activity
Updated 14 Jul 2026
1 congress contribution (2022) across ASH per OpenAlex. The most recent:
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Comparison of broad-spectrum anti-Pseudomonal beta-lactam antibiotics versus targeted therapy for neutropenic patients with methicillin-susceptible Staphylococcus aureus bloodstream infections.
Antimicrobial stewardship & healthcare epidemiology
2025 - Informing estimates of probability of Clostridioides difficile infection for testing and treatment: expert consensus from a modified-Delphi procedure.
Antimicrobial stewardship & healthcare epidemiology
2024 - Comparison of Clostridioides difficile nucleic acid amplification test (NAAT) results using fresh and frozen stool specimens and rectal swabs.
Journal of clinical microbiology
2024
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
4523 Clayton Ave., MSC 8051-0043-15, St. Louis, MO 63110
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Infectious Diseases Fellowship
Washington University School of Medicine/Barnes-Jewish Hospital, St. Louis, MO
2005verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Board Certified
Infectious Diseases
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Editorial & leadership rolesjournal and society appointments
- Lead/co-author
'Strategies to Prevent Clostridioides difficile Infections in Acute-Care Hospitals: 2022 Update' (SHEA/IDSA compendium)
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pmc.ncbi.nlm.nih.gov ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- Expert panel author/contributor
SHEA/IDSA 2017 Clinical Practice Guideline Update for Clostridium difficile Infection in Adults and Children
2017verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →idsociety.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Secondary affiliationsappointments beyond the home institution
- Clinical Director
Transplant Infectious Diseases Consult Service, Washington University/Barnes-Jewish Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Director of Infectious Diseases Epidemiology Research
Washington University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗ - Associate Hospital Epidemiologist
Barnes-Jewish Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
Media & interviewspress, podcasts and appearances
- Video presenter
'Costs of Care Considerations in Clostridium difficile' (YouTube, Peer Voice/education series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - Video presenter
'Monitoring for Treatment Response in C. difficile' (educational video series)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →m.youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/erik-dubberke-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/p/DNHTyIyR7IJ
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
infectiousdiseases.wustl.edu/people/erik-dubberke
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →infectiousdiseases.wustl.edu ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Mark Huffman, MD
Washington University in St. Louis
- 437
- publications
- 61
- h-index
- 6
- trials
Eric Lenze, MD
Washington University in St. Louis
- 546
- publications
- 74
- h-index
- 24
- trials
John Newcomer, MD
Washington University in St. Louis
- 248
- publications
- 63
- h-index
- 11
- trials
Elvin Geng, MD
Washington University in St. Louis
- 400
- publications
- 60
- h-index
- 2
- trials